Viatris and Idorsia seal research and development deal for two phase III assets by Editor | Mar 2, 2024 | LATEST NEWS, WORLD NEWS | 0 SWITZERLAND — Swiss pharmaceutical company Idorsia has recently secured a vital financial lifeline... Read More